  
|
|
|
 |
2003 |
|
|
November 18, 2003
|
MG98 Preclinical Synergy Data With Interferon First Disclosed At AACR-NCI-EORTC 2003
|
October 27, 2003
|
MethylGene Reports Progress on Isotypic-Selective HDAC Inhibitor Chemistries for Oncology
|
October 20, 2003
|
MethylGene Announces Oncology Collaboration worth US$37.5 Million
|
September 23, 2003
|
MethylGene Expands Chemistry Leadership
|
September 17, 2003
|
MethylGene Receives Key Patents Protecting Cancer and Infectious Disease Programs
|
June 24, 2003
|
MethylGene Signs Worldwide Agreement with Merck-Frosst Canada & Co. on antibiotic resistance program
|
June 2, 2003
|
MethylGene Discloses DNA Methylation Results of Clinical Samples from MG98-treated Patients at ASCO 2003
|
May 28, 2003
|
MethylGene Announces Appointment of Dr. Nafsika Georgopapadakou as Vice-President of Infectious Disease
|
April 3, 2003
|
MethylGene Publishes Phase I Results for Anti-cancer Compound and Presents New Scientific Findings on Anti-cancer Target
|
February 25, 2003
|
MethylGene Receives Key Patent Protecting Anti-cancer Compound
|
January 8, 2003
|
MethylGene Reports Scientific Progress in Two Anticancer Programs
|
|
|
 
|
|
 |
|
